← Leaderboards
Charles Chiedu Nwaokobia
Evon Medics, Llc
$4,402,384
Attributed
$11,642,151
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,642,151 · 4
By mechanism
R44$11,642,151 · 4
Top collaborators
- Evaristus A Nwulia14 shared
- Sumeet Seth8 shared
- Vamsi Reddy3 shared
Most similar at Evon Medics, Llc
Same institution · by research overlap
- Evaristus A Nwulia$14,602,860
- Sumeet Seth$2,844,919
- Vamsi Reddy$982,458
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposEvaluationDevicesPsychophysicsSmall Business Innovation Research GrantInnovationProviderUniversitiesCommunitiesProgramsPortabilityOlfactory CortexComputerizedImpaired CognitionTrainingDigitalComorbidityEfficacy StudyStimulantHomePathologicRandomized TrialFeedbackMarketing
Grant awards (14)
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,280,870
R44 · FY2025 · NS · contact PI
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
R44 · FY2025 · AG · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,349,130
R44 · FY2024 · NS · contact PI
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
R44 · FY2024 · AG · contact PI
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,219,088
R44 · FY2024 · DA · contact PI
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,318,829
R44 · FY2023 · DA · contact PI
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$448,887
R44 · FY2023 · AG · contact PI
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$55,000
R44 · FY2023 · DA · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,245,116
R44 · FY2022 · AG
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$499,999
R44 · FY2022 · NS · contact PI
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$330,680
R44 · FY2022 · DA · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease$98,280
R44 · FY2022 · AG
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$50,000
R44 · FY2022 · AG
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,247,784
R44 · FY2021 · AG